PRVANasdaqServices-Health ServicesFiscal year ends December 31

Privia Health Group, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$22.44−0.08 (-0.36%)

Close on Oct 19, 2026

Market cap: $2.96B
P/E (TTM): 106.9
Dividend yield: –

Privia Health Group, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q2 2026 2026-06-30	TTM Q1 2026 2026-03-31	TTM FY 2025 2025-12-31	TTM Q3 2025 2025-09-30	TTM Q2 2025 2025-06-30	TTM Q1 2025 2025-03-31	TTM FY 2024 2024-12-31	TTM Q3 2024 2024-09-30	TTM Q2 2024 2024-06-30	TTM Q1 2024 2024-03-31	TTM FY 2023 2023-12-31	TTM Q3 2023 2023-09-30	TTM Q2 2023 2023-06-30	TTM Q1 2023 2023-03-31	TTM FY 2022 2022-12-31	TTM Q3 2022 2022-09-30	TTM Q2 2022 2022-06-30	TTM Q1 2022 2022-03-31	TTM FY 2021 2021-12-31	TTM Q3 2021 2021-09-30	TTM Q2 2021 2021-06-30	TTM Q1 2021 2021-03-31	TTM FY 2020 2020-12-31
Revenue	2,358	2,247	2,123	2,043	1,900	1,801	1,736	1,716	1,696	1,687	1,658	1,581	1,507	1,429	1,357	1,268	1,176	1,066	966	905	860	818	817
Selling, General & Admin	180	176	165	170	162	153	153	148	144	141	134	132	135	140	149	159	160	302	279	254	228	59	55
Selling & Marketing	30	28	27	27	27	27	26	26	26	26	25	24	22	20	20	18	18	24	23	23	21	12	11
General & Administrative	150	148	138	143	134	126	126	121	118	116	110	108	113	119	130	141	142	278	256	231	207	47	44
Operating Expenses	2,313	2,210	2,089	2,014	1,880	1,780	1,719	1,703	1,683	1,672	1,637	1,560	1,496	1,430	1,376	1,308	1,225	1,303	1,184	1,099	1,033	791	792
Operating Income	45	36	34	28	20	21	17	13	13	15	21	21	11	-0.86	-19	-41	-49	-237	-217	-194	-173	27	25
Interest Expense	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.00	1.10	1.30	1.50	1.70	1.90
Other Non-Operating Income	–	8.66	9.70	10	10	11	11	11	12	9.54	8.37	–	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	56	45	44	39	30	32	28	24	25	24	29	28	15	1.73	-19	-42	-50	-238	-219	-195	-174	25	23
Income Tax Expense	22	18	14	14	11	12	11	10	8.60	6.62	7.99	-7.40	-15	-11	-6.52	-0.71	1.92	-24	-28	-20	-27	-6.14	-7.44
Net Income incl. Noncontrolling Interests	34	27	30	25	19	20	17	14	16	18	21	36	30	12	-12	-41	-52	-214	-191	-175	-147	31	31
Minority Interest in Earnings	5.71	5.63	6.81	6.34	3.84	4.41	2.66	1.18	1.03	-1.06	-2.05	-2.47	-3.83	-3.82	-3.48	-2.46	-3.17	-3.21	-2.42	-2.59	-0.90	-0.04	-0.34
Net Income	28	22	23	18	15	16	14	13	15	19	23	38	34	16	-8.59	-38	-49	-211	-188	-172	-147	31	31
EPS (Basic)(per share)	0.22	0.17	0.19	0.15	0.12	0.13	0.12	0.11	0.13	0.16	0.20	0.33	0.29	0.13	-0.08	-0.36	-0.46	-2.04	-1.83	-1.67	-1.41	0.33	0.33
EPS (Diluted)(per share)	0.21	0.16	0.18	0.13	0.11	0.12	0.11	0.10	0.12	0.15	0.19	0.33	0.29	0.13	-0.08	-0.36	-0.46	-2.04	-1.83	-1.67	-1.41	0.33	0.33
Shares Outstanding (Basic, Weighted)(shares)	124	123	122	121	121	120	119	119	118	118	117	116	114	112	111	109	107	106	103	100	98	96	96
Shares Outstanding (Diluted, Weighted)(shares)	130	130	129	128	127	126	126	125	125	125	125	122	122	118	111	112	107	106	103	100	98	96	96
EBITDA	57	48	44	37	28	29	24	20	20	22	27	27	17	3.93	-15	-36	-45	-234	-215	-192	-171	29	27
Net Interest Income	–	–	–	–	–	–	–	–	–	9.54	8.37	6.68	4.07	2.59	0.54	-0.80	-1.37	-1.01	-1.07	-1.32	-1.53	-1.74	-1.92

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 1.9%
Net margin: 1.2%
Return on equity, FY2025: 3.3%

Financial strength

Current ratio: 1.62
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 65.0%

Valuation

P/E ratio: 106.9
Price to sales: 1.25
Price to book: 3.78
Dividend yield: –